Supports Loop's Infinite Loop™ India project by further expanding customer base.
Loop transforms textile waste into high-purity Twist™ polyester, which Hyosung TNC will convert into high-performance yarns under its Regen™ portfolio, trusted by leading apparel and textile brands.
PharmaNest Inc. announced today a multi-institutional research collaboration with Virginia Commonwealth University (VCU) and the National Institutes of Health (NIH) to confirm the prognostic performance of artificial intelligence (AI) powered digital pathology biomarkers in metabolic dysfunction-associated steatotic liver disease (MASLD) in a retrospective cohort of 1,765 patients with MASH (NASH CRN DB2 Cohort)
Read More
Google's Kapil Dabi and OpenAI's Zach Lawryk join Jesse Itzler, Kevin Harrington, Neil Patel and more, alongside new panels designed to deliver tactical insights for affiliates, agencies and SaaS operators.
Read More
With high-value assets including a LeBron James 2016 NBA Finals game worn jersey and rare Tom Brady 1/1 card, Infinite Auctions bolsters MDCE's balance sheet to accelerate development of its AI health platform.
Read More
MIXT IV Spa, a Modern Health and Wellness Destination, is Excited to Announce Its Opening in Los Alamitos, Proudly Serving the Community and Nearby Cities Including Rossmoor, Seal Beach, Long Beach, Belmont Shore and Cypress
Read MoreNew Deployment Showcases ARIA Cybersecurity's Commitment to Safeguarding Mid-Sized Manufacturers with 24x7 Managed Service that Ensures Compliance and Protects Critical Operations Without Costly Upgrades
Read MoreIcotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1
Filing based on four Phase 3 studies that met all primary and co-primary endpoints. This unprecedented data package includes head-to-head superiority comparisons versus deucravacitinib, adolescent data, and evaluation of difficult to treat skin sites2,3,4,5,6
Submission underscores that icotrokinra has the potential to offer moderate-to-severe plaque psoriasis patients the combination of complete skin clearance and a favourable safety profile, relative to comparators, with the simplicity of a once-daily tablet. 2,3,4,5,6
Read More